Sampre Nutritions Intrinsic Value
SAMPRE Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹19.68 | ₹15.74 - ₹23.62 | -21.6% | EPS: ₹1.64, Sector P/E: 12x |
| Book Value Method | asset | ₹43.33 | ₹39.00 - ₹47.66 | +72.6% | Book Value/Share: ₹43.33, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹15.24 | ₹13.72 - ₹16.76 | -39.3% | Revenue/Share: ₹19.05, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹18.52 | ₹16.67 - ₹20.37 | -26.2% | EBITDA: ₹8.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹25.87 | ₹20.70 - ₹31.04 | +3.1% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹10.50 | ₹9.45 - ₹11.55 | -58.2% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹13.51 | ₹12.16 - ₹14.86 | -46.2% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| Graham Defensive Method | conservative | ₹39.99 | ₹35.99 - ₹43.99 | +59.3% | EPS: ₹1.64, BVPS: ₹43.33 |
Want to compare with current market value? Check SAMPRE share price latest .
Valuation Comparison Chart
SAMPRE Intrinsic Value Analysis
What is the intrinsic value of SAMPRE?
Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Sampre Nutritions (SAMPRE) is ₹19.68 (median value). With the current market price of ₹25.10, this represents a -21.6% variance from our estimated fair value.
The valuation range spans from ₹10.50 to ₹43.33, indicating ₹10.50 - ₹43.33.
Is SAMPRE undervalued or overvalued?
Based on our multi-method analysis, Sampre Nutritions (SAMPRE) appears to be trading above calculated value by approximately 21.6%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 1.45 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Debt to Equity Ratio | 1.26 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
| Return on Equity | 4.4% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 20.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.35x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
Related Pages for Sampre Nutritions
Additional stock information and data for SAMPRE
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹0 Cr | ₹-38 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹4 Cr | ₹2 Cr | Positive Free Cash Flow | 7/10 |
| March 2023 | ₹1 Cr | ₹-1 Cr | Positive Operating Cash Flow | 6/10 |